Nichols, Garcia & Sanders-Bush (2003). Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration. Brain Research: Molecular Brain Research.
Rickert et al. (2003). Prevalence and risk factors for LSD use among young women. Journal of Pediatric and Adolescent Gynecology.
Tomie et al. (2003). Effects of autoshaping procedures on 3H-8-OH-DPAT-labeled 5-HT1a binding and 125I-LSD-labeled 5-HT2a binding in rat brain. Brain Research.
Zghoul & Blier (2003). Enhancing action of LSD on neuronal responsiveness to serotonin in a brain structure involved in obsessive-compulsive disorder. The International Journal of Neuropsychopharmacology.
Appel, West & Buggy (2004). LSD, 5-HT (serotonin), and the evolution of a behavioral assay. Neuroscience and Biobehavioral Reviews.
Cui et al. (2004). Quantitation of lysergic acid diethylamide in urine using atmospheric pressure matrix-assisted laser desorption/ionization ion trap mass spectrometry. Analytical Chemistry.
Muschamp et al. (2004). Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex. Brain Research.
Nichols & Sanders-Bush (2004). Molecular genetic responses to lysergic acid diethylamide include transcriptional activation of MAP kinase phosphatase-1, C/EBP-beta and ILAD-1, a novel gene with homology to arrestins. Journal of Neurochemistry.
Sunness (2004). Persistent afterimages (palinopsia) and photophobia in a patient with a history of LSD use.
Winter, Eckler & Rabin (2004). Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli. Psychopharmacology.
Benneyworth et al. (2005). Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice. Psychopharmacology.
Dyck (2005). Flashback: psychiatric experimentation with LSD in historical perspective. Canadian Journal of Psychiatry.
Gresch et al. (2005). Behavioral Tolerance to Lysergic Acid Diethylamide is Associated with Reduced Serotonin-2A Receptor Signaling in Rat Cortex. Neuropsychopharmacology.
Johansen & Jensen (2005). Liquid chromatography-tandem mass spectrometry determination of LSD, ISO-LSD, and the main metabolite 2-oxo-3-hydroxy-LSD in forensic samples and application in a forensic case. Journal of Chromatography.
Marona-Lewicka, Thisted & Nichols (2005). Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis. Psychopharmacology.
Mashour (2005). Altered states: LSD and the Anesthesia Laboratory of Henry Knowles Beecher. Bulletin of Anesthesia History.
Minuzzi et al. (2005). Interaction between LSD and dopamine D2/3 binding sites in pig brain. Synapse.
Reissig et al. (2005). The 5-HT1A receptor and the stimulus effects of LSD in the rat. Psychopharmacology.
Seeman, Ko & Tallerico (2005). Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics. Molecular Psychiatry.
Winter et al. (2005). The stimulus properties of LSD in C57BL/6 mice. Pharmacology, Biochemistry, and Behavior.
Arvanian et al. (2006). Combined treatment with neurotrophin-3 and LSD facilitates behavioral recovery from double-hemisection spinal injury in neonatal rats. Journal of Neurotrauma.
Dyck (2006). 'Hitting highs at rock bottom': LSD treatment for alcoholism, 1950-1970. Social History of Medicine.
Hecker (2006). [100 years Albert Hofmann: LSD--miracle drug and problem child, Basel, January 13-15, 2006]. Psychiatrische Praxis.
Jerie (2006). [Hundred years of Albert Hofmann, the discoverer of LSD]. Casopis Lekaru Ceskych.
Sewell, Halpern & Pope (2006). Response of cluster headache to psilocybin and LSD. Neurology.
Marona-Lewicka & Nichols (2007). Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action. Pharmacology, Biochemistry, and Behavior.
Mashour (2007). From LSD to the IRB: Henry Beecher's psychedelic research and the foundation of clinical ethics. International Anesthesiology Clinics.
Goldman, Galarneau & Friedman (2007). New Onset LSD Flashback Syndrome Triggered by the Initiation of SSRIs. The Ochsner Journal.
Gresch et al. (2007). 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide. The Journal of Pharmacology and Experimental Therapeutics.
Favretto et al. (2007). LC-ESI-MS/MS on an ion trap for the determination of LSD, iso-LSD, nor-LSD and 2-oxo-3-hydroxy-LSD in blood, urine and vitreous humor. International Journal of Legal Medicine.
Kozarich (2007). New LSD therapies unfolding. Chemistry & Biology.
Sigafoos et al. (2007). Flashback to the 1960s: LSD in the treatment of autism. Developmental Neurorehabilitation.
Vidal & Skripuletz (2007). Bupropion interference with immunoassays for amphetamines and LSD. Therapeutic Drug Monitoring.
Fusar-Poli & Borgwardt (2008). Albert Hofmann, the father of LSD (1906-2008). Neuropsychobiology.
Green (2008). Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5-HT in the UK. British Journal of Pharmacology.
Krall et al. (2008). Marked decrease of LSD-induced stimulus control in serotonin transporter knockout mice. Pharmacology, Biochemistry, and Behavior.
Passie et al. (2008). The pharmacology of lysergic acid diethylamide: a review. CNS Neuroscience and Therapeutics.
Raval et al. (2008). Percutaneous transluminal angioplasty in the treatment of extensive LSD-induced lower extremity vasospasm refractory to pharmacologic therapy. Journal of Vascular and Interventional Radiology.
Reissig et al. (2008). d-LSD-induced c-Fos expression occurs in a population of oligodendrocytes in rat prefrontal cortex. European Journal of Pharmacology.
Chapuis-Hugon et al (2009). Selective sample pretreatment by molecularly imprinted polymer for the determination of LSD in biological fluids. Journal of Separation Science.
Chung, Hudson & McKay (2009). Validated ultra-performance liquid chromatography-tandem mass spectrometry method for analyzing LSD, iso-LSD, nor-LSD, and O-H-LSD in blood and urine. Journal of Analytical Toxicology.
Marona-Lewicka, Chemel & Nichols (2009). Dopamine D₄ receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI. Psychopharmacology.
Seeman, Guan & Hirbec (2009). Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil. Synapse.
Winter (2009). Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines. Psychopharmacology.
Berrens, Lammers & White (2010). Rhabdomyolysis After LSD Ingestion. Psychosomatics.
Colace (2010). Drug dreams in mescaline and LSD addiction. The American Journal on Addictions.
Grossman et al. (2010). Characterization of behavioral and endocrine effects of LSD on zebrafish. Behavioural Brain Research.
Halberstadt & Geyer (2010). LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT 2A receptor. Psychopharmacology.
Iaria et al. (2010). A case of persistent visual hallucinations of faces following LSD abuse: A functional magnetic resonance imaging study. Neurocase.
Karst et al. (2010). The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: an open, non-randomized case series. Cephalalgia.
Killinger, Peet & Baker (2010). Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague-Dawley rats. Pharmacology, Biochemistry, and Behavior.